Minnesota Woman Who Lost $156,000 Files Abilify Gambling Lawsuit

A few years ago, long before she would even think about filing her Abilify gambling lawsuit, Denise Miley had what appeared to be the perfect life. She and her husband lived in a beautiful home in Maple Grove, Minnesota, with their four sons. Her career as a CPA was enjoyable [...]

By | May 23rd, 2017|Abilify News, Pharma News|

$3M Jury Verdict Against GSK in Landmark Paxil Suicide Case

April 20, 2017, Chicago, Illinois - - A federal jury has sided with the widow of a deceased Chicago attorney in her generic Paxil suicide lawsuit against GlaxoSmithKline (GSK), ordering the pharmaceutical giant to pay $3 million. The jury verdict resolves allegations in the trial of Dolin v. Smithkline Beecham [...]

Bristol-Myers Squibb Will Pay $19.5 Billion in Abilify Settlement

Last month, pharmaceutical company Bristol-Myers Squibb agreed to pay $19.5 million to settle a multi-state lawsuit that charged the company with improper marketing of the atypical antipsychotic Abilify. Abilify is made by Otsuka America Pharmaceutical, Inc. and marketed and promoted in the United States by Bristol-Myers Squibb. Money from the [...]

By | January 20th, 2017|Abilify News, Pharma News|

U.S. Abilify Warning Label Now Includes Compulsive Gambling

The popular antipsychotic Abilify (aripiprazole) received approval from the U.S. Food and Drug Administration (FDA) in 2002 for the treatment of bipolar disorder, schizophrenia and other major depressive disorders. Since then, there have been over 180 reported instances of impulse control problems among Abilify users, including compulsive gambling, shopping, binge [...]

By | September 26th, 2016|Abilify News, Pharma News|

Celexa, Lexapro and the Death of Evidence-Based Medicine

“Oh, what a tangled web we weave. When first we practise to deceive!” From Walter Scott’s epic poem, Marmion This is the story of a drug and an idea, and how, in 2004, the rise of one helped bring about the downfall of the other. The drug is Celexa (generic [...]

Antidepressant Suicide – A Catch-22

Justice has been served! $3 Million jury verdict against GSK in landmark generic Paxil suicide case What’s wrong with this picture? Company A designs a drug. The company develops it, tests it on animals and ultimately humans, and sends the results of their research—or what they claim are the results—to [...]

By | July 20th, 2016|Blog, Paxil News, Pharma News, R. Brent Wisner|

Paxil Suicide Case Heads to Trial

Justice has been served! $3 Million jury verdict against GSK in landmark generic Paxil suicide case No More Stalling of Paxil Suicide Case Chicago, Illinois, January 14, 2016 — A federal judge in Illinois has ruled that a Paxil suicide case alleging GlaxoSmithKline (“GSK”) concealed data linking its antidepressant drug Paxil [...]

By | January 14th, 2016|Blog, Paxil News, Pharma News, Press Releases|

Attorney Tells All: How the U.S. Courts Shield Big Pharma from Liability

It’s not easy to sue Big Pharma.  But, legal firm Baum Hedlund has been doing it for years.  Unfortunately, as pharmaceutical deceit and side-effects grow, it’s getting exponentially more difficult.  After all, using prescription drugs as prescribed is the top killer in the USA. I reached out to attorney Michael Baum to get a [...]

By | November 23rd, 2015|Blog, Michael L. Baum, Pharma News, Press Releases|

Study Data Does Not Support Conclusion that FDA Warnings May Have Led to More Suicides

In a highly publicized article published in the British Medical Journal (BMJ) on June 18, 2014, “Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study,” Dr. Lu and colleagues suggest the FDA’s warnings regarding an increased risk of suicidality in children and [...]

By | November 15th, 2015|Bijan Esfandiari, Pharma News|

Twenty First Century Snake Oil Salesman

A Modern Tale of Perfidy and Comeuppance (A “Fiction” inspired by an article in the September 17, 2015 issue of The Chronicle of Higher Education) Here’s the deal: A medical doctor who acts as a “key opinion leader” (KOL) for Big Pharma puts his or her name on an article [...]

By | September 18th, 2015|Blog, Paxil News, Pharma News, Rons Rants|